[New concepts in multiple myeloma by returning to cytogenetics]

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Context:

• Multiple myeloma (MM) exhibits significant genomic instability, leading to genetic alterations, disease progression, and treatment resistance.
• Mechanisms include impaired DNA repair (e.g., TP53 loss), mitotic errors (e.g., BUB1 abnormalities), cell cycle dysregulation, and tumor microenvironment factors.
• Cytogenetic abnormalities are crucial prognostic indicators and influence treatment strategies involving various drug classes.

Purpose:

• To develop advanced diagnostic tools for chromosomal analysis in multiple myeloma.
• To enhance the sensitivity and convenience of cytogenetic diagnosis for MM patients.

Summary:

• The study introduces two novel fluorescence in situ hybridization (FISH) techniques: immunophenotyped-suspension-multiplex (ISM)-FISH and amplified FISH (amFISH).
• ISM-FISH enables simultaneous detection of three IGH-related chromosomal translocations using imaging flow.
• amFISH employs signal amplification for high-sensitivity detection of microdeletions in small chromosomal regions (<100 kb), such as 1p32 (CDKN2C) and 14q32 (TRAF3).

Impact:

• These innovative FISH modalities improve chromosomal diagnostic capabilities for multiple myeloma.
• They facilitate a more rapid, cytogenetics-guided therapeutic approach, even alongside clinical sequencing.
• Enhanced diagnostic precision can lead to more personalized and effective MM treatment strategies.